4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001079973-26-000439
Chief Executive Officer disposed of 98,534 shares (other)
- Chief Executive Officer acquired 670,608 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Virnich Daniel · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-27 | Grant or award : show line 1 in the form | −670,608 | 2,458,758 | D | ||
| 2026-03-27 | Other disposition : show line 2 in the form | −98,534 | $3.07 | $302,499 | 2,360,224 | D |
Loading xslF345X06/ownership.xml…